47045-PAK-T-MC-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Tuberculosis - Pakistan (01-Oct-2012-30-Jun-2015)</narrative> Pakistan, Tuberculosis, Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Izaskun Gaviria Fund Portfolio Manager +41 58 791 1700 izaskun.gaviria@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 1633192.00 Global Fund disbursement to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3196659.00 Global Fund disbursement to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2273996.00 Global Fund disbursement to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 8064554.00 Global Fund commitment to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2978263.00 Global Fund commitment to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -960707.00 Global Fund commitment to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2203207.00 Global Fund disbursement to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -775056.00 Global Fund commitment to PAK-T-MCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. 47045-PAK-T-MC-2 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>NULL - Pakistan (01-Jul-2015-31-Dec-2017)</narrative> Pakistan, Tuberculosis, Mercy Corps Goals: Contribute to achieving the goal of the national strategy to control TB in Pakistan which is to reduce by 50% the prevalence of TB by 2025 in comparison to 2011; Contribute towards decreasing the prevalence, by at least 5% per year from 2018 onwards, the prevalence of MDR-TB among TB patients who have never received any TB treatment. Objectives: To enhance MDR-TB enrolment from 18% of estimated cases in 2013-14 to 23% of estimated by 2017; To increase TB case notification (all forms) from 61% of estimated incident cases in 2013-14 to 71% of estimated incident cases by 2017 while maintaining treatment success rate at 91%; To increase the number of TB patients who are screened for HIV infection from 3% in 2013-14 to 10% by 2017. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Izaskun Gaviria Fund Portfolio Manager +41 58 791 1700 izaskun.gaviria@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 5840360.00 Global Fund commitment to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1412769.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1058185.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1194039.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2175367.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 7833228.00 Global Fund commitment to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1738760.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1209362.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1913018.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2972088.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 892661.00 Global Fund commitment to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 892661.00 Global Fund disbursement to PAK-T-MCP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>CM-other 1: Number of notified TB cases, all forms, contributed by non-NTP providers - private/non-governmental facilities</narrative> Module: TB care and prevention. <narrative>CM-other 1: Number of notified TB cases, all forms, contributed by non-NTP providers - private/non-governmental facilities</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 7843. Numerator: 8444. Numerator: 7843; Denominator: 85492; Percentage: 9.2%. Numerator: 8418. Numerator: 16392. Numerator: 13125. Numerator: 19613. Numerator: 14944. Numerator: 21350. Numerator: 16994. Numerator: 19513. <narrative>CM-other 2 Number of bacteriologically confirmed TB, New and relapse cases, contributed by non-NTP- private/non-governmental facilities</narrative> Module: TB care and prevention. <narrative>CM-other 2 Number of bacteriologically confirmed TB, New and relapse cases, contributed by non-NTP- private/non-governmental facilities</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 2704. Numerator: 4248. Numerator: 2704; Denominator: 36670; Percentage: 7.4%. Numerator: 4203. Numerator: 5238. Numerator: 6583. Numerator: 6402. Numerator: 7473. Numerator: 7272. Numerator: 8520. Numerator: 6327. <narrative>CM-other 3: Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period in non-NTP providers -private/non-governmental facilit</narrative> Module: TB care and prevention. <narrative>CM-other 3: Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period in non-NTP providers -private/non-governmental facilit</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 2534; Denominator: 2745. Numerator: 2034; Denominator: 2234. Numerator: 2534; Denominator: 2745. Numerator: 3669; Denominator: 4024. Numerator: 2919; Denominator: 3126. Numerator: 2461; Denominator: 2704. Numerator: 2502; Denominator: 2704. Numerator: 3825; Denominator: 4203. Numerator: 4822; Denominator: 5238. Numerator: 5991; Denominator: 6583. Numerator: 5914; Denominator: 6402. 47045-PAK-T-MC-3 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Contribute towards achieving the targets of National Strategic Plan aligned with End TB Strategy for reducing the burden of TB and MDR-TB in Pakistan - Pakistan (01-Jan-2018-30-Jun-2021)</narrative> Pakistan, Tuberculosis, Mercy Corps Goals: Contribute to achieving the goal of the national strategy to control TB in Pakistan which is to reduce by 50% the prevalence of TB by 2025 in comparison to 2011; Contribute towards decreasing the prevalence, by at least 5% per year from 2018 onwards, the prevalence of MDR-TB among TB patients who have never received any TB treament. Objectives: To increase TB case notification (all forms) from 70% of estimated incident cases in 2014-15 to 85% of estimated incident cases by 2020 while maintaining treatment success rate at 91%; To enhance MDR-TB enrollment from 18% of estimated cases in 2014-15 to 33% of estimated by 2020; To increase the number of TB patients who are screened for HIV infection from 3% in 2014-15 to 10% by 2020. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Izaskun Gaviria Fund Portfolio Manager +41 58 791 1700 izaskun.gaviria@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage Multicomponent -> Payment for results -> Payment for results Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency RSSH -> RSSH: Health management information systems and M&E -> Routine reporting Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention) Tuberculosis -> TB care and prevention -> Community TB care delivery Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention) Tuberculosis -> TB care and prevention -> Key populations (TB care and prevention) - Others Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) 3694161.76 3688455.51 6383803.71 6077387.97 5280682.66 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 350821.66 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 985145.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 835133.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 946873.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1218876.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -943834.00 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 5835494.33 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1922422.89 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 161378.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1721245.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1549312.57 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -481135.87 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2719272.54 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1172555.08 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1546717.46 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3383374.00 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3383374.00 Global Fund disbursement to PAK-T-MCP03 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 13290.00 Funds returned to the Global Fund from PAK-T-MCP03 (International NGO). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria -13290.00 Global Fund commitment to PAK-T-MCP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3694161.74 Expenditure reported by Mercy Corps for PAK-T-MCP03, Jan 2018 to Dec 2018. Mercy Corps 3687998.98 Expenditure reported by Mercy Corps for PAK-T-MCP03, Jan 2019 to Dec 2019. Mercy Corps 4985034.98 Expenditure reported by Mercy Corps for PAK-T-MCP03, Jan 2020 to Dec 2020. Mercy Corps 3360613.58 Expenditure reported by Mercy Corps for PAK-T-MCP03, Jan 2021 to Jun 2021. Mercy Corps -431405.05 Expenditure reported by Mercy Corps for PAK-T-MCP03, Jul 2021 to Dec 2021. Mercy Corps <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative> <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 2481; Denominator: 66714. Numerator: 4522; Denominator: 60062. Numerator: 1443; Denominator: 38916. <narrative>TCP Other- 4: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> <narrative>TCP Other- 4: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 12562; Denominator: 33405. Numerator: 11286; Denominator: 45046. Numerator: 12152; Denominator: 32113. <narrative>TCP Other-2: Number of samples tested on Xpert through specimen transportation</narrative> <narrative>TCP Other-2: Number of samples tested on Xpert through specimen transportation</narrative> Aggregation: Non cumulative. <narrative>TCP Other-3: Proportion of contacts of people with bacteriologically confirmed TB who were screened for active TB</narrative> <narrative>TCP Other-3: Proportion of contacts of people with bacteriologically confirmed TB who were screened for active TB</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 1397; Denominator: 27233. Numerator: 31036; Denominator: 56429. Numerator: 16090; Denominator: 24607. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative> Module: TB care and prevention. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 30894. Numerator: 314632. Numerator: 314632. Numerator: 314632. Numerator: 314632. Numerator: 314632. Numerator: 314632. Numerator: 314632. Numerator: 41758. Numerator: 41758. Numerator: 41758. Numerator: 41758. Numerator: 41758. Numerator: 41758. Numerator: 41758. Numerator: 137718. Numerator: 176440. Numerator: 176440. Numerator: 176440. Numerator: 176440. Numerator: 176440. Numerator: 176440. Numerator: 176440. Numerator: 179950. Numerator: 179950. Numerator: 179950. Numerator: 179950. Numerator: 179950. Numerator: 179950. Numerator: 179950. Numerator: 19308. Numerator: 18084. Numerator: 16348; Denominator: 18084; Percentage: 90.4%. Numerator: 1736; Denominator: 18084; Percentage: 9.6%. Numerator: 8821; Denominator: 18084; Percentage: 48.8%. Numerator: 9263; Denominator: 18084; Percentage: 51.2%. Numerator: 19308. Numerator: 18169. Numerator: 15746; Denominator: 18169; Percentage: 86.7%. Numerator: 2423; Denominator: 18169; Percentage: 13.3%. Numerator: 8744; Denominator: 18169; Percentage: 48.1%. Numerator: 9425; Denominator: 18169; Percentage: 51.9%. Numerator: 19308. Numerator: 19603. Numerator: 16988; Denominator: 19603; Percentage: 86.7%. Numerator: 2615; Denominator: 19603; Percentage: 13.3%. Numerator: 9336; Denominator: 19603; Percentage: 47.6%. Numerator: 10267; Denominator: 19603; Percentage: 52.4%. Numerator: 21098. Numerator: 18998. Numerator: 15968; Denominator: 18998; Percentage: 84.1%. Numerator: 3030; Denominator: 18998; Percentage: 15.9%. Numerator: 9158; Denominator: 18998; Percentage: 48.2%. Numerator: 9840; Denominator: 18998; Percentage: 51.8%. Numerator: 23473. Numerator: 18332. Numerator: 16065; Denominator: 18332; Percentage: 87.6%. Numerator: 2267; Denominator: 18332; Percentage: 12.4%. Numerator: 8701; Denominator: 18332; Percentage: 47.5%. Numerator: 9631; Denominator: 18332; Percentage: 52.5%. Numerator: 23476. Numerator: 21037. Numerator: 18323; Denominator: 21037; Percentage: 87.1%. Numerator: 2714; Denominator: 21037; Percentage: 12.9%. Numerator: 9885; Denominator: 21037; Percentage: 47%. Numerator: 11152; Denominator: 21037; Percentage: 53%. Numerator: 60062. Numerator: 38916. Numerator: 33668; Denominator: 38916; Percentage: 86.5%. Numerator: 5248; Denominator: 38916; Percentage: 13.5%. Numerator: 6346; Denominator: 20266; Percentage: 31.3%. Numerator: 18491; Denominator: 38916; Percentage: 47.5%. Numerator: 20425; Denominator: 38916; Percentage: 52.5%. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: Subnational. Aggregation: Cumulative annually. Numerator: 187; Denominator: 228. Numerator: 255; Denominator: 300. Numerator: 289; Denominator: 299. Numerator: 261; Denominator: 300. Numerator: 215; Denominator: 237. Numerator: 300; Denominator: 333. Numerator: 245; Denominator: 257. Numerator: 338; Denominator: 375. Numerator: 296; Denominator: 309. <narrative>TCP other 1: Number of cases notified through chest camps</narrative> Module: TB care and prevention. <narrative>TCP other 1: Number of cases notified through chest camps</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 13544; Denominator: 14212. Numerator: 14755; Denominator: 15866. Numerator: 17094; Denominator: 18141. Numerator: 13550; Denominator: 14570. Numerator: 15809; Denominator: 16767. Numerator: 17956; Denominator: 19308. Numerator: 16947; Denominator: 18084. Numerator: 17956; Denominator: 19308. Numerator: 17057; Denominator: 18168. Numerator: 17956; Denominator: 19308. Numerator: 18444; Denominator: 19510. Numerator: 19619; Denominator: 21098. Numerator: 18006; Denominator: 18998. Numerator: 37174; Denominator: 39972. Numerator: 29291; Denominator: 31766. 47045-PAK-T-MC-4 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Contribute towards achieving the targets of National Strategic Plan aligned with End TB Strategy for reducing the burden of TB and MDR-TB in Pakistan. - Pakistan (01-Jul-2021-31-Dec-2023)</narrative> Pakistan, Tuberculosis, Mercy Corps Goals: To reduce TB mortality rate by 40% by 2023 compared to 2015; To reduce estimated TB incidence by at least 4% in 2023 compared to 2015. Objectives: To detect and notify at least 1,300,000 cases of new TB episode during the years 2021 to 2023; To maintain the annual treatment success rate at 90% and over during the years 2021 to 2023; To enroll in treatment with 2nd line TB medicines 21,000 cases of MDR/RR-TB cases during the years 2021 to 2023; To ensure the provision of preventive TB therapy to at least 650,000 eligible people during the years 2021 to 2023. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Izaskun Gaviria Fund Portfolio Manager +41 58 791 1700 izaskun.gaviria@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage Multicomponent -> Payment for results -> Payment for results Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Analysis, evaluations, reviews and transparency RSSH -> RSSH: Health management information systems and M&E -> Routine reporting Tuberculosis -> TB care and prevention -> Case detection and diagnosis (TB care and prevention) Tuberculosis -> TB care and prevention -> Community TB care delivery Tuberculosis -> TB care and prevention -> Engaging all care providers (TB care and prevention) Tuberculosis -> TB care and prevention -> Treatment (TB care and prevention) Tuberculosis -> TB/HIV -> Engaging all care providers (TB/HIV) 8578888.26 8842268.48 15794543.27 13140259.88 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 4648214.16 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3917249.96 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -4574795.76 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 15786993.18 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2336654.18 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2808808.83 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 5303324.00 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 7843751.00 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -5338206.17 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3709174.00 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2297737.57 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 4134577.00 Global Fund disbursement to PAK-T-MCP04 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2040267.78 Global Fund disbursement to PAK-T-MCP04 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 221553.00 Global Fund disbursement to PAK-T-MCP04 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -35916.79 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 23448.68 Funds returned to the Global Fund from PAK-T-MCP04 (Pooled Procurement Mechanism). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria -23448.68 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 215100.00 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -215100.00 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -215100.00 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 215100.00 Funds returned to the Global Fund from PAK-T-MCP04 (Pooled Procurement Mechanism). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria 44847.00 Funds returned to the Global Fund from PAK-T-MCP04 (International NGO). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria -44847.00 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -1764946.00 Global Fund commitment to PAK-T-MCP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1764946.00 Funds returned to the Global Fund from PAK-T-MCP04 (Other 3rd Party). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria 3963010.00 Expenditure reported by Mercy Corps for PAK-T-MCP04, Jul 2021 to Dec 2021. Mercy Corps 8298920.78 Expenditure reported by Mercy Corps for PAK-T-MCP04, Jan 2022 to Dec 2022. Mercy Corps 16689950.40 Expenditure reported by Mercy Corps for PAK-T-MCP04, Jan 2023 to Dec 2023. Mercy Corps -943129.34 Expenditure reported by Mercy Corps for PAK-T-MCP04, Jan 2024 to Jun 2024. Mercy Corps <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2020 - Funding Request - Window 3 - Tuberculosis - Pakistan - English</narrative> Funding Request of funding request FR743-PAK-T-01. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative> Module: TB care and prevention. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative> Module: TB care and prevention. <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - private/non-governmental facilities</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Module: TB care and prevention. <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 215; Denominator: 237. Numerator: 658; Denominator: 715. Numerator: 559; Denominator: 574. Numerator: 704; Denominator: 757. Numerator: 643; Denominator: 664. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative> Module: TB care and prevention. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 2481; Denominator: 66714. Numerator: 8291; Denominator: 84266. Numerator: 4916; Denominator: 48398. Numerator: 9563; Denominator: 90994. Numerator: 8746; Denominator: 67657. Numerator: 19126; Denominator: 181988. Numerator: 19746; Denominator: 140896. Numerator: 9563; Denominator: 90994. Numerator: 11000; Denominator: 73239. Numerator: 19136; Denominator: 186310. Numerator: 30195; Denominator: 183046. Numerator: 9568; Denominator: 93155. Numerator: 13555; Denominator: 88882. Numerator: 9568; Denominator: 93155. Numerator: 16640; Denominator: 94164. <narrative>TCP Other -1: Number of samples tested on Xpert through specimen transportation</narrative> Module: TB care and prevention. <narrative>TCP Other -1: Number of samples tested on Xpert through specimen transportation</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. <narrative>TCP Other- 3: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> Module: TB care and prevention. <narrative>TCP Other- 3: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 12562; Denominator: 33405. Numerator: 24666; Denominator: 61691. Numerator: 14047; Denominator: 37073. Numerator: 33070; Denominator: 66486. Numerator: 19772; Denominator: 51025. Numerator: 66140; Denominator: 132972. Numerator: 39899; Denominator: 110416. Numerator: 33070; Denominator: 66486. Numerator: 20127; Denominator: 59391. Numerator: 40966; Denominator: 68305. Numerator: 26613; Denominator: 72684. Numerator: 81932; Denominator: 136610. Numerator: 54685; Denominator: 149436. Numerator: 40966; Denominator: 68305. Numerator: 28072; Denominator: 76752. <narrative>TCP Other-2: Proportion of contacts of people with bacteriologically confirmed TB who were screened for active TB</narrative> Module: TB care and prevention. <narrative>TCP Other-2: Proportion of contacts of people with bacteriologically confirmed TB who were screened for active TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 13970; Denominator: 27233. Numerator: 71739; Denominator: 130435. Numerator: 37481; Denominator: 55721. Numerator: 194052; Denominator: 323420. Numerator: 103835; Denominator: 163100. Numerator: 97026; Denominator: 161710. Numerator: 49028; Denominator: 80079. Numerator: 97026; Denominator: 161710. Numerator: 54807; Denominator: 83021. Numerator: 286764; Denominator: 409664. Numerator: 154252; Denominator: 235328. Numerator: 143382; Denominator: 204832. Numerator: 74702; Denominator: 113152. Numerator: 143382; Denominator: 204832. Numerator: 79550; Denominator: 122176. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Module: TB care and prevention. <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 59283; Denominator: 65065. Numerator: 40338; Denominator: 43375. Numerator: 33968; Denominator: 36553. Numerator: 134225; Denominator: 144328. Numerator: 82376; Denominator: 87398. Numerator: 55858; Denominator: 60062. Numerator: 36702; Denominator: 39024. Numerator: 78367; Denominator: 84266. Numerator: 45674; Denominator: 48374. Numerator: 169248; Denominator: 181988. Numerator: 132293; Denominator: 140051. Numerator: 84624; Denominator: 90994. Numerator: 63193; Denominator: 67203. Numerator: 84624; Denominator: 90994. Numerator: 69100; Denominator: 72848. 47045-PAK-T-MC-5 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Contribution toward achieving the targets of National Strategic Plan for Tuberculosis prevention, care and control in Pakistan - Pakistan (01-Jan-2024-31-Dec-2026)</narrative> Pakistan, Tuberculosis, Mercy Corps Goal: To reduce TB mortality rate by 35% in 2026 compared to 2015. Objectives: To increase the number of notified new TB episodes to at least 486,160 by 2026 and to maintain TB treatment success rate at more than 90% from 2024 onwards; To increase the number of detected and treated of MDR/RR-TB cases from 3,373 in 2021 to at least 7,700 by 2026 and their treatment success rate to at least 80% from 2024 onwards; To increase the proportion of notified TB cases with known HIV status from 52% in 2021 to 100 % by 2026 and to treat 100% of identified TB/HIV with ART every year; To improve and enhance TB prevention through i) tuberculosis preventive therapy of, at least, 80% of household contacts and PLHIV with no active TB in 2024 to 2026 and ii) strengthening infection control. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Izaskun Gaviria Fund Portfolio Manager +41 58 791 1700 izaskun.gaviria@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Pakistan Tuberculosis Multicomponent Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage Multicomponent -> Program management -> Grant management Tuberculosis -> Collaboration with other providers and sectors -> Private provider engagement in TB/DR-TB care Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST) Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis Tuberculosis -> TB/DR-TB Prevention -> Preventive treatment Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions 10178954.99 12316490.10 12169432.95 21244330.91 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2907387.49 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3953783.00 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 215100.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 215100.00 Global Fund disbursement to PAK-T-MCP05 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 5336231.08 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 36050.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2697441.48 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 4841476.01 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -6349487.86 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1897108.00 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2882320.00 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 36050.00 Global Fund disbursement to PAK-T-MCP05 (Pooled Procurement Mechanism). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1764946.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1764946.00 Global Fund disbursement to PAK-T-MCP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 5968634.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -62048.01 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3025709.00 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps -2942925.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 7956024.58 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 152190.03 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2040904.58 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 12846.00 Global Fund disbursement to PAK-T-MCP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 12846.00 Global Fund disbursement to PAK-T-MCP05 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 5901.00 Funds returned to the Global Fund from PAK-T-MCP05 (International NGO). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria -5901.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 3077422.00 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 932.00 Funds returned to the Global Fund from PAK-T-MCP05 (International NGO). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria -932.00 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 1303.46 Funds returned to the Global Fund from PAK-T-MCP05 (Pooled Procurement Mechanism). Mercy Corps The Global Fund to Fight AIDS, Tuberculosis and Malaria -1303.46 Global Fund commitment to PAK-T-MCP05. The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 2812006.00 Global Fund disbursement to PAK-T-MCP05 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Mercy Corps 10124512.99 Expenditure reported by Mercy Corps for PAK-T-MCP05, Jan 2024 to Dec 2024. Mercy Corps 11076457.00 Expenditure reported by Mercy Corps for PAK-T-MCP05, Jan 2025 to Dec 2025. Mercy Corps <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2023 - Funding Request - Window 1 - Tuberculosis - Pakistan - English</narrative> Funding Request of funding request FR1402-PAK-T. 1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons. 2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation. 3 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement. 4 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of USD 27,253,483 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction with the Host Country’s compliance with the requirements listed at 5.4(1)(a) and 5.4(1)(b) below (“Co-Financing Requirements”). The Grantee acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: (a) progressively increase government expenditure on health to meet national universal health coverage goals; and/or (b) increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee acknowledges and agrees that the Host Country shall, as set out in the co-financing commitment letter to be signed by the Government of the Islamic Republic of Pakistan and submitted in form and substance satisfactory to the Global Fund, by 15 January 2024: (a) fulfil a total minimum co-financing commitment for period of 2024-2026; (b) fulfil the programmatic commitments (if any) as stipulated in the co-financing commitment letter; (c) submit all supporting documents evidencing such commitments at provincial and federal levels in the form of official budgets and allocations; and (d) submit by no later than 15 January 2024 complete and accurate data for the allocation, release and actual budget expenditure for TB and RSSH disease components for the period of 2021-2023, and with all expenditure classified by geography, object and function, as in the Charts of Accounts; and (e) provide to the Global Fund, by no later than the agreed date of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including but not limited to: i. the approved annual budget for HIV, TB and Malaria for the upcoming year; and ii. the total expenditure for HIV, TB and Malaria in the previous fiscal year. 5 - The Global Fund may disburse Grant Funds in a currency other than that specified in the Grant Confirmation. In such cases, the exchange rate used to calculate the amount of the disbursement into its equivalent in the currency specified in the Grant Confirmation shall be the relevant exchange rate reflected in the Program budget. 7 - The Principal Recipient acknowledges the obligation to repay to the Global Fund the amounts the Global Fund has determined as recoverable pursuant to the terms of the relevant grant agreements: a. USD 1,155 arising from financial review of July-December 2021 PUDR, as communicated to the Principal Recipient through the demand letter dated 11 November 2022; and b. USD 20,949 arising from financial review of Jan-June 2021 PUDR, as communicated to the Principal Recipient through the demand letter dated 19 July 2022. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 940. Numerator: 914; Denominator: 940; Percentage: 97.23%. Numerator: 26; Denominator: 940; Percentage: 2.77%. Numerator: 439; Denominator: 799; Percentage: 54.94%. Numerator: 501; Denominator: 940; Percentage: 53.3%. Numerator: 915. Numerator: 1926. Numerator: 1481. Numerator: 1011. Numerator: 832. Numerator: 2596. Numerator: 1802. Numerator: 1263. Numerator: 1333. Numerator: 892. Numerator: 865. Numerator: 27. Numerator: 421. Numerator: 471. Numerator: 1395. Numerator: 1413. <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative> Module: RSSH/PP: Laboratory systems (including national and peripheral). <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other. Numerator: 664; Denominator: 686. Numerator: 808; Denominator: 851. Numerator: 808; Denominator: 851. Numerator: 808; Denominator: 851. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 140896. Numerator: 116535; Denominator: 140896; Percentage: 82.71%. Numerator: 24361; Denominator: 140896; Percentage: 17.29%. Numerator: 39898; Denominator: 140896; Percentage: 28.32%. Numerator: 65589; Denominator: 140896; Percentage: 46.55%. Numerator: 75306; Denominator: 140896; Percentage: 53.45%. Numerator: 157286. Numerator: 204181. Numerator: 74819. Numerator: 82467. Numerator: 105406. Numerator: 208992. Numerator: 206354. Numerator: 101997. Numerator: 106995. Numerator: 100877. Numerator: 85615. Numerator: 15262. Numerator: 36679. Numerator: 47844. Numerator: 53033. Numerator: 110970. Numerator: 112868. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 57236; Denominator: 140896. Numerator: 70778.8; Denominator: 157286. Numerator: 97301; Denominator: 204181. Numerator: 33668.55; Denominator: 74819. Numerator: 37110.15; Denominator: 82467. Numerator: 42221; Denominator: 105406. Numerator: 114945.7; Denominator: 208992. Numerator: 110274; Denominator: 206354. Numerator: 56098.35; Denominator: 101997. Numerator: 58847.25; Denominator: 106995. Numerator: 54596; Denominator: 100877. Numerator: 72130.5; Denominator: 110970. Numerator: 73364.2; Denominator: 112868. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 10624; Denominator: 140896. Numerator: 18453.4; Denominator: 157286. Numerator: 11112; Denominator: 204181. Numerator: 8239.74; Denominator: 74819. Numerator: 10213.74; Denominator: 82467. Numerator: 6375; Denominator: 105406. Numerator: 20511.4; Denominator: 208992. Numerator: 13408; Denominator: 206354. Numerator: 10255.74; Denominator: 101997. Numerator: 10255.74; Denominator: 106995. Numerator: 7737; Denominator: 100877. Numerator: 10255.74; Denominator: 110970. Numerator: 10255.74; Denominator: 112868. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 130870; Denominator: 140896. Numerator: 138833; Denominator: 157286. Numerator: 193179; Denominator: 204181. Numerator: 66579.7; Denominator: 74819. Numerator: 72253.3; Denominator: 82467. Numerator: 99090; Denominator: 105406. Numerator: 188480.6; Denominator: 208992. Numerator: 193138; Denominator: 206354. Numerator: 91741.3; Denominator: 101997. Numerator: 96739.3; Denominator: 106995. Numerator: 93337; Denominator: 100877. Numerator: 100714.3; Denominator: 110970. Numerator: 102612.3; Denominator: 112868. <narrative>TBDT-Other 1: Percentage of samples tested using GeneXpert out of the total number of samples transported through specimen transportation</narrative> Module: TB diagnosis, treatment and care. <narrative>TBDT-Other 1: Percentage of samples tested using GeneXpert out of the total number of samples transported through specimen transportation</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 40143; Denominator: 60274. Numerator: 55064; Denominator: 84714. Numerator: 238774; Denominator: 314408. Numerator: 21341; Denominator: 32833. Numerator: 33723; Denominator: 51881. Numerator: 111305; Denominator: 140421. Numerator: 141834; Denominator: 202619. Numerator: 330280; Denominator: 352575. Numerator: 61848; Denominator: 88354. Numerator: 79986; Denominator: 114265. Numerator: 179614; Denominator: 186964. Numerator: 107138; Denominator: 142850. Numerator: 127220; Denominator: 169626. <narrative>TBDT-Other 2: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> Module: TB diagnosis, treatment and care. <narrative>TBDT-Other 2: Proportion of bacteriologically positive TB cases among new and relapse pulmonary TB cases.</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 39899; Denominator: 110416. Numerator: 59000; Denominator: 117964.8. Numerator: 62989; Denominator: 164418. Numerator: 28061; Denominator: 56114.3. Numerator: 30939; Denominator: 61850.5. Numerator: 32190; Denominator: 82870. Numerator: 45909; Denominator: 76497.9. Numerator: 94059; Denominator: 156744.4. Numerator: 75195; Denominator: 161178. Numerator: 48150; Denominator: 80246.5. Numerator: 36679; Denominator: 78303. Numerator: 54096; Denominator: 83227.7. Numerator: 55016; Denominator: 84651.2. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 82242; Denominator: 87398. Numerator: 134146.1; Denominator: 149051.2. Numerator: 172760; Denominator: 183046. Numerator: 67072.32; Denominator: 74524.8. Numerator: 67073.76; Denominator: 74526.4. Numerator: 88739; Denominator: 94164. Numerator: 67337.1; Denominator: 74819. Numerator: 141557.4; Denominator: 157286. Numerator: 187202; Denominator: 204178. Numerator: 74220.3; Denominator: 82467. Numerator: 95014; Denominator: 105404. Numerator: 91797.3; Denominator: 101997. Numerator: 96295.5; Denominator: 106995. <narrative>Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative> Module: TB/DR-TB Prevention. <narrative>Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 103835; Denominator: 163100. Numerator: 77196; Denominator: 140305. Numerator: 162305; Denominator: 295000. Numerator: 164866; Denominator: 268343. Numerator: 85109; Denominator: 154695. Numerator: 78566; Denominator: 132261. Numerator: 305752; Denominator: 470295. Numerator: 188338; Denominator: 308528. Numerator: 149236; Denominator: 229545. Numerator: 156516; Denominator: 240750. Numerator: 93171; Denominator: 151011. Numerator: 202889; Denominator: 270480. Numerator: 206328; Denominator: 275080. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Module: TB/DR-TB Prevention. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.